A Randomized comparative clinical study to evaluate the efficacy of vedanasthapana anal suppository and vedanasthapana taila matrabasti in the management of kashtartava (Primary dysmenorrhea)
Phase 3
- Conditions
- Health Condition 1: N944- Primary dysmenorrhea
- Registration Number
- CTRI/2023/07/055586
- Lead Sponsor
- Parul Ayurved Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
i.Patients with chief complaint of lower abdomen pain during menstruation with regular cycle (21-35 days) with VAS score more than 4.
ii.Age groups between 18 to 30 years shall be selected.
iii.Patients suffering from dysmenorrhea for at least 3 cycles in last 6 months.
iv.Married and unmarried women will be incorporated for the study.
v.Patients fit for matrabasti and suppository use.
Exclusion Criteria
i.Any space occupying lesion.
ii.Women with Irregular menstrual cycles.
iii.Secondary dysmenorrhea.
iv.IUCD
v.Women diagnosed with congenital anomalies of reproductive tract.
vi.Systemic or metabolic disorders which can be contraindicated for matrabasti or suppository use.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Evaluate the efficacy of vedanastapana anal suppository and vedanasthapana taila matrabasti in the management of kashtartava(primary dysmenorrhea)Timepoint: baseline, consecutive 4 menstrual cycles for 4 months
- Secondary Outcome Measures
Name Time Method Evaluate the efficacy of vedanastapana anal suppository & vedanasthapana taila matrabasti in the management of kashtartava (primary dysmenorrhea) & in consecutive cycles after 2 months of treatmentTimepoint: consecutive 2 menstrual cycles after 2 cycles of treatment